McKesson Ventures in the News

Real-World Evidence Should Be Part of Clinical Trials in Oncology OncLive

McKesson’s Sarah Alwardt, Ph.D, recently wrote in OncLive about the importance of real-world evidence (RWE) in the field of cancer treatment research. Fewer than 5 percent of adults with cancer enroll in clinical trials, but sufficient enrollment is necessary in order to successfully complete randomized controlled...

Global Corporate Venturing logo

McKesson Ventures’ Carrie Hurwitz Williams Recognized as GCV Rising Star

McKesson Ventures Principal Carrie Hurwitz Williams has been honored as one of 10 Global Corporate Venturing Rising Stars. Williams joined McKesson Ventures in 2017, bringing with her more than 15 years of experience in health care from several vantage points within the industry. She was attracted...

Matternet Raises Strategic Investment from McKesson Ventures PR Newswire

Matternet, a company focused on providing drone delivery for medical applications, announced a strategic investment from McKesson Ventures. McKesson Ventures joins Matternet’s current investors, Boeing, Sony, and Mercedes-Benz, along with a growing list of strategic partners including UPS and Swiss Post. Matternet has created a new...

Silicon Valley Boomer Venture Summit logo

Silicon Valley Boomer Venture Summit Announces Finalists for $10K Business Plan Competition and The Silicon Valley Innovation Competition 2019, Sponsored by AARP Innovation Labs

The finalists have been announced for this year’s Business Plan Competition and AARP Innovation Labs Pitch Competition. The business plan competition features companies pitching their ideas to a diverse panel of judges for feedback, funding, and a $10,000 prize. Judges for the business plan competition were...

McKesson Ventures Director Irem Mertol was recently featured in Startup Health magazine.

Investors to Watch: Irem Mertol

McKesson Ventures Director Irem Mertol was featured as an investor to watch in the latest issue of Startup Health magazine. Mertol, whose work focuses on early to growth-stage investments across healthcare technology and services, has been with McKesson Ventures since 2017. Her most recent investment was...

Global Corporate Venturing logo

GCV Powerlist 2018: Tom Rodgers

Tom Rodgers, senior vice president and managing director of McKesson Ventures, has been named to the Global Corporate Venturing 2018 Powerlist. Under Tom Rodgers’ leadership, McKesson Ventures (which launched in 2014) has made several investments, including a $1.2 billion series B round for GRAIL Inc. in...

Wall Street Journal

Venture Investors: Theranos’s Fall Underscores Need for Transparency

Medical startups need to communicate their progress well, or they set themselves up for failure. Theranos Inc. is the most recent example of how negligence can carry big consequences. Venture capitalists and entrepreneurs attribute the company’s downfall to a failure to be transparent in dealings...

It’s California’s second richest company, but you probably haven’t heard of it

What’s the second richest company in California? If you can’t answer that question, you aren’t the only one. The answer? McKesson Corporation. According to Fortune, McKesson is “a massive corporation hiding in plain sight.” A distributor of pharmaceuticals and other medical supplies, McKesson is often overlooked...